Biospecifics Technologies (BSTC) Income Statement

Click line-items for a historical chart and %

Net sales
Royalties	6.12M
Licensing revenues	762.35K
Consulting fees
Total Revenues	6.88M
Research and development	312.91K
General and administrative	1.84M
Total Cost and Expenses	2.16M
Operating income (loss)	4.73M
Interest income	80.67K
Other income (expense)
Total Other income (expense)	86.93K
Income (loss) before expense for income tax	4.81M
Income tax benefit (expense)	-1.76M
Net income (loss)	3.05M
Basic net income (loss) per share	0.43
Diluted net income (loss) per share	0.42
Shares used in computation of basic net income (loss) per share	7.06M
Shares used in computation of diluted net income (loss) per share	7.28M

Entities mentioned with BSTC

View All Entities